Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1.70
Market cap: ₹6.80 Cr
Revenue (annual): ₹115.9 Cr
Net profit (annual): ₹0.39 Cr
P/E (TTM): 15.0×Sector 47.3×
Promoter holding: 20.02%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 5 Other Announcement 4 Financial Results 3 Management Change 2 Fund Raise 1 Debt & Borrowing 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

7 Aug 2026 13:12 IST BSE

Financial Results

Vivanza Biosciences Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY

Vivanza Biosciences Ltd reported revenue from operations of ₹9.3 Cr (+4.5% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.

Key figure: Net profit ₹0.1 Cr · +0.0% YoY

Open full results → Read the filing ↗

7 May 2026 22:58 IST BSE

Financial Results

Vivanza Biosciences Q4 FY26 Results: Net Loss of ₹0.5 Cr, Loss Narrows

Vivanza Biosciences Ltd reported revenue from operations of ₹6.4 Cr (+1180.0% YoY) and a net loss of ₹0.5 Cr for Q4 FY26.

Key figure: Net loss ₹0.5 Cr

Open full results → Read the filing ↗

7 May 2026 22:58 IST BSE

Financial Results

Vivanza Biosciences Financial Results

Vivanza Biosciences reported audited standalone annual revenue of ₹112.34 Crore. The Board also noted resignations of its Director and Company Secretary during the meeting.

Value: ₹112.3 Cr

Read the filing ↗